The effects of an APOE promoter polymorphism on human cortical morphology during nondemented aging

Journal of Neuroscience

Volumn 35, Issue 4, 2015, Pages 1423-1431

  Chen, Yaojing ^a   Li, Peng ^b   Gu, Bin ^a   Liu, Zhen ^a   Li, Xin ^a   Evans, Alan C ^c   Gong, Gaolang ^a   Zhang, Zhanjun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b XIYUAN HOSPITAL   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

APOE promoter polymorphism; Cortical thickness; Nondemented aging; Rs405509; Surface area; Thickness covariance

Indexed keywords

APOLIPOPROTEIN E;

ADRENAL CORTEX; ADULT; AGED; AGING; APOLIPOPROTEIN E PROMOTER POLYMORPHISM; ARTICLE; BODY SURFACE; CORTICAL THICKNESS (BRAIN); FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; AGE; ANATOMY AND HISTOLOGY; BRAIN CORTEX; COGNITION; GENETICS; PHYSIOLOGY; PROMOTER REGION; PSYCHOLOGICAL RATING SCALE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; CEREBRAL CORTEX; COGNITION; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; STATISTICS AS TOPIC;

EID: 84921909712     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1946-14.2015     Document Type: Article

References (49)

1. Aminoff EM, Kveraga K, Bar M (2013) The role of the parahippocampal cortex in cognition. Trends Cogn Sci 17:379-390. CrossRef Medline
2. Artiga MJ, Bullido MJ, Sastre I, Recuero M, García MA, Aldudo J, Vàzquez J, Valdivieso F (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 421:105–108. CrossRef Medline
3. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the Alz- Gene database. Nat Genet 39:17–23. CrossRef Medline
4. Beyer K, Lao JI, Gòmez M, Riutort N, Latorre P, Mate JL, Ariza A (2002) The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset. Neurosci Lett 326:187–190. CrossRef Medline
5. Bookheimer S, Burggren A (2009) APOE-4 genotype and neurophysiological vulnerability to Alzheimer’s and cognitive aging. Annu Rev Clin Psychol 5:343–362. CrossRef Medline
6. Chen ZJ, He Y, Rosa-Neto P, Germann J, Evans AC (2008) Revealing modular architecture of human brain structural networks by using cortical thickness from MRI. Cereb Cortex 18:2374-2381. CrossRef Medline
7. Chung MK, Worsley KJ, Robbins S, Paus T, Taylor J, Giedd JN, Rapoport JL, Evans AC (2003) Deformation-based surface morphometry applied to gray matter deformation. Neuroimage 18:198-213. CrossRef Medline
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923. CrossRef Medline
9. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59:746-748. CrossRef Medline
10. Engqvist L (2005) The mistreatment of covariate interaction terms in linear model analyses of behavioural and evolutionary ecology studies. Anim Behav 70:967–971. CrossRef
11. Evans AC (2013) Networks of anatomical covariance. Neuroimage 80:489-504. CrossRef Medline
12. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356. CrossRef Medline
13. Fennema-Notestine C, Panizzon MS, Thompson WR, Chen CH, Eyler LT, Fischl B, Franz CE, Grant MD, Jak AJ, Jernigan TL, Lyons MJ, Neale MC, Seidman LJ, Tsuang MT, Xian H, Dale AM, Kremen WS (2011) Presence of ApoE epsilon4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis 26 [Suppl 3]:49–60. CrossRef Medline
14. Gong G, He Y, Chen ZJ, Evans AC (2012) Convergence and divergence of thickness correlations with diffusion connections across the human cerebral cortex. Neuroimage 59:1239-1248. CrossRef Medline
15. He Y, Chen Z, Evans A (2008) Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer’s disease. J Neurosci 28:4756–4766. CrossRef Medline
16. Honea RA, Vidoni E, Harsha A, Burns JM (2009) Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 18:553–564. CrossRef Medline
17. Kabani N, Le Goualher G, MacDonald D, Evans AC (2001) Measurement of cortical thickness using an automated 3-D algorithm: a validation study. Neuroimage 13:375–380. CrossRef Medline
18. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, Guennel T, Shin Y, Johnson MB, Krsnik Z, Mayer S, Fertuzinhos S, Umlauf S, Lisgo SN, Vortmeyer A, Weinberger DR, et al. (2011) Spatio-temporal transcriptome of the human brain. Nature 478: 483–489. CrossRef Medline
19. Kim JS, Singh V, Lee JK, Lerch J, Ad-Dab’bagh Y, MacDonald D, Lee JM, Kim SI, Evans AC (2005) Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 27:210-221. CrossRef Medline
20. Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC (1998a) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer’s disease. Hum Mol Genet 7:533–540. CrossRef Medline
21. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pèrez-Tur J, Mouroux V, Mohr M, Ceècyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC (1998b) Pronounced impact of Th1/E47cs mutation compared with 491 AT mutation on neural APOE gene expression and risk of developing Alzheimer’s disease. Hum Mol Genet 7:1511–1516. CrossRef Medline
22. Lambert JC, Brousseau T, Defosse V, Evans A, Arveiler D, Ruidavets JB, Haas B, Cambou JP, Luc G, Ducimetieère P, Cambien F, Chartier-Harlin MC, Amouyel P (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet 9:57–61. CrossRef Medline
23. Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, Harris JM, Artiga MJ, Hernandez D, Kwon JM, Frigard B, Petersen RC, Cumming AM, Pasquier F, Sastre I, Tienari PJ, Frank A, Sulkava R, Morris JC, St Clair D, et al. (2002) Contribution of APOE promoter polymorphisms to Alzheimer’s disease risk. Neurology 59:59–66. CrossRef Medline
24. Lambert JC, Coyle N, Lendon C (2004) The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease. J Med Genet 41:104-112. CrossRef Medline
25. Lambert JC, Mann D, Richard F, Tian J, Shi J, Thaker U, Merrot S, Harris J, Frigard B, Iwatsubo T, Lendon C, Amouyel P (2005) Is there a relation between APOE expression and brain amyloid load in Alzheimer’s disease? J Neurol Neurosurg Psychiatry 76:928-933. CrossRef Medline
26. Laws SM, Hone E, Gandy S, Martins RN (2003) Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84:1215–1236. CrossRef Medline
27. Lemaîitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alpèrovitch A, Mazoyer B (2005) Noepsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24:1205-1213. CrossRef Medline
28. Lerch JP, Evans AC (2005) Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 24:163–173. CrossRef Medline
29. Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy. Cereb Cortex 15:995–1001. CrossRef Medline
30. Lerch JP, Worsley K, Shaw WP, Greenstein DK, Lenroot RK, Giedd J, Evans AC (2006) Mapping anatomical correlations across cerebral cortex (MACACC) using cortical thickness from MRI. Neuroimage 31:993-1003. CrossRef Medline
31. Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer’s patients from normal elderly controls. Neurobiol Aging 29:23–30. CrossRef Medline
32. Lescai F, Chiamenti AM, Codemo A, Pirazzini C, D’Agostino G, Ruaro C, Ghidoni R, Benussi L, Galimberti D, Esposito F, Marchegiani F, Cardelli M, Olivieri F, Nacmias B, Sorbi S, Tagliavini F, Albani D, Martinelli Boneschi F, Binetti G, Santoro A, et al. (2011) An APOE haplotype associated with decreased epsilon4 expression increases the risk of late onset Alzheimer’s disease. J Alzheimers Dis 24:235–245. CrossRef Medline
33. Lyttelton OC, Karama S, Ad-Dab’bagh Y, Zatorre RJ, Carbonell F, Worsley K, Evans AC (2009) Positional and surface area asymmetry of the human cerebral cortex. Neuroimage 46:895–903. CrossRef Medline
34. Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Pèrez-Tur J, Lahiri DK (2010) Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: differential effects in neuronal cells and on DNA-protein interactions. AmJ Med Genet B Neuropsychiatr Genet 153B:185–201. CrossRef Medline
35. Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol 6:37–48. CrossRef Medline
36. Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson K, Lyons MJ, Grant MD, Franz CE, Xian H, Tsuang M, Fischl B, Seidman L, Dale A, Kremen WS (2009) Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex 19:2728-2735. CrossRef Medline
37. Raznahan A, Lerch JP, Lee N, Greenstein D, Wallace GL, Stockman M, Clasen L, Shaw PW, Giedd JN (2011) Patterns of coordinated anatomical change in human cortical development: a longitudinal neuroimaging study of maturational coupling. Neuron 72:873-884. CrossRef Medline
38. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ (2004) Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 63:2354-2359. CrossRef Medline
39. Schmitt JE, Lenroot RK, Wallace GL, Ordaz S, Taylor KN, Kabani N, Greenstein D, Lerch JP, Kendler KS, Neale MC, Giedd JN (2008) Identification of genetically mediated cortical networks: a multivariate study of pediatric twins and siblings. Cereb Cortex 18:1737–1747. CrossRef Medline
40. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 6:494-500. CrossRef Medline
41. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97. CrossRef Medline
42. Sowell ER, Peterson BS, Kan E, Woods RP, Yoshii J, Bansal R, Xu D, Zhu H, Thompson PM, Toga AW (2007) Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 17:1550-1560. CrossRef Medline
43. Taylor JE, Adler RJ (2003) Euler characteristics for Gaussian fields on manifolds. Ann Probab 31:533–563. CrossRef
44. Tohka J, Zijdenbos A, Evans A (2004) Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 23:84-97. CrossRef Medline
45. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatr 72:491-497. Medline
46. Wang L, Li H, Liang Y, Zhang J, Li X, Shu N, Wang YY, Zhang Z (2013) Amnestic mild cognitive impairment: topological reorganization of the default-mode network. Radiology 268:501–514. CrossRef Medline
47. Xie S, Zhang Z, Zhao Q, Zhang J, Zhong S, Bi Y, He Y, Pan H, Gong G (2014) The effects of X chromosome loss on neuroanatomical and cognitive phenotypes during adolescence: a multi-modal structural MRI and diffusion tensor imaging study. Cereb Cortex. Advance online publication. Retrieved May 10, 2014. doi:10.1093/cercor/bhu079.
48. Yao Z, Hu B, Liang C, Zhao L, Jackson M, Alzheimer’s Disease, Neuroimaging I (2012) A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness. PLoS One 7:e48973. CrossRef Medline
49. Ye S, Dunleavey L, Bannister W, Day LB, Tapper W, Collins AR, Day IN, Simpson I, Southampton Atherosclerosis S (2003) Independent effects of the -219 G_T and epsilon 2/epsilon 3/epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. Eur J Hum Genet 11:437-443. CrossRef Medline